Merck Approves all Agenda Items at Annual General Meeting

30 April 2023 | Sunday | News

Merck held its 28th Annual General Meeting virtually today. All of the resolutions on the agenda were approved, including the proposed dividend of € 2.20 per share.

Merck, a leading science and technology company, held its 28th Annual General Meeting virtually today. All of the resolutions on the agenda were approved, including the proposed dividend of € 2.20 per share.

Shareholders also voted to authorize the Executive Board to decide on the appropriate format of the Annual General Meetings in 2024 and 2025, i.e. whether they will be held either virtually or in person. The Executive Board will take into account factors such as sustainability, costs, health and safety, the agenda items, and ensuring the broadest possible participation of shareholders.

At the Annual General Meeting , around 93.8 million shares of the approximately 129.2 million shares issued were represented in the vote. This corresponds to 72.59% of the share capital.

The details of the voting results and further information can be found at www.merckgroup.com/agm.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close